AzTrials
AzTrials

PathologyNCT04383249

Routine Pathological Examination of Hernia Sac; Is it a Workload or Necessary?

An observational study of Pathology, run by Dr. Ersin Arslan Education and Training Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Routine microscopic examination of the hernia sac is controversial. While some centers do not recommend a routine microscopic examination in inguinal hernias in adult patients, they recommend them in abdominal wall hernias. Read more about this study

Who is it for?
Any age
Conditions the study is for
Pathology
What is being tested?
Pathology result
How many people
437 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2020to 7 May 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: Patients who have operated hernia and sent hernia sac for histopathological examination.

Who may be able to join

  • Emergency operated patients
  • Elective operated patients

Who cannot join

  • Hernia repairs without pathology examinations

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Dr. Ersin Arslan Training and Resource Hospital

    Gaziantep

Other trials in Turkey (Türkiye)

About this study

Routine microscopic examination of the hernia sac is controversial. While some centers do not recommend a routine microscopic examination in inguinal hernias in adult patients, they recommend them in abdominal wall hernias. The investigators aimed to discuss the pathology results and unexpected histopathological findings who underwent abdominal wall and inguinal hernia operation in the light of the literature.

Read the detailed description

The hernia is defined as the passage of an organ or tissue from one anatomical region to another. Hernia sacs are sent to the pathology department, although there is a difference between clinics. Routine microscopic examination of the hernia sac is controversial. While some centers do not recommend a routine microscopic examination in inguinal hernias in adult patients, they recommend them in abdominal wall hernias. Here, the investigators aimed to discuss the pathology results and unexpected histopathological findings who underwent abdominal wall and inguinal hernia operation in the light of the literature. Patients who have operated hernia and sent hernia sac for histopathological examination were retrospectively screened. Emergency and elective operated patients were included. Hernia repairs without pathology were excluded from the study. Patients' gender, age, operation notes, and pathology results were analyzed. Pathology results were analyzed in two groups as expected findings and unexpected findings. In our study, the probability of encountering an unexpected pathological result was found to be quite low in the pathological evaluation of the hernia sac. Although it may cause additional workload and cost, all hernia sacs should be sent to routine pathological examination. The investigators believe that making savings in these areas through further investigation after the decision of the pathologist.

Conditions
Pathology
Being tested
Pathology result
Keywords
Hernia sac, inguinal hernia, incisional hernia, intestine, omentum
Medical subject headings
Hernia, Inguinal, Incisional Hernia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pathology resultDiagnostic test

    Pathology result of the hernia sac

Study groups in NCT04383249
Study groupRoleWhat they receive
Pathology resultPathology result of the hernia sac
Receives: Diagnostic Test: Pathology result

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. unexpected finding

    rate of unexpected result

    Measured: 2 or 3 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2020
  2. Study start1 Jan 2020
  3. Primary completion1 May 2020
  4. Study completion7 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
437 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04383249
Sponsor's protocol ID
07052020
Status last verified
May 2020
First submitted
7 May 2020
Last updated
12 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pathology, run by Dr. Ersin Arslan Education and Training Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

unexpected finding (time frame: 2 or 3 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in